LifeStance Q1 revenue up 21% to $403.5M; net income $14.2M; raises FY guidance

LifeStance Health Group, Inc.

Revenue $403.5M (+21% YoY); net income $14.2M vs $0.7M; Adjusted EBITDA $51.1M (+48%).
Clinician base up 11% to 8,349 (net +309); visit volumes up 18% to 2.5M.
Center Margin $135.9M (33.7% of revenue) vs $109.8M (33.0%).
FY2026 guidance raised: revenue $1.64B-1.68B, Adj EBITDA $200M-220M; Q2 rev $405M-425M.
Free cash flow $22.3M; cash $194.8M; net debt $262.5M.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

LifeStance Health Group, Inc. reported the first quarter ended March 31, 2026 results: revenue $403.5 million, net income $14.2 million. Guidance raised.

Period: the first quarter ended March 31, 2026
Revenue: $403.5 million
Net income: $14.2 million
Guidance: raised
Result: reported results

Exact text from the filing

for the first quarter ended March 31, 2026. (All results compared to prior-year comparative period, unless otherwise noted) 2026 Highlights and FY 2026 Outlook • Revenue of $403.5 million increased 21% compared to revenue of $333.0 million • Clinician base increased 11% to 8,349 clinicians, a sequential net increase of 309 in the first quarter • First quarter

View on SEC.gov

Browse all earnings releases →

LifeStance Health Group, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-209709

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.